GlassScriptPhysician profile
Walter L Taylor
NPI 1992709620
$7,388.45
in general payments reported to CMS, 2019-2025
53 companies · $2,158 in 2025
The $2,158 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $61.73 · 2021: $118 · 2022: $523 · 2023: $1,769 · 2024: $2,448 · 2025: $2,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,350 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23.52 · Education: $1.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,350.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23.52 |
| Education | $1.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $980.10 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Pfizer INC. | $485.17 | 2023-2025 | |
| Ucb, INC. | $464.81 | 2022-2025 | Rystiggo, Briviact |
| Sk Life Science, INC. | $356.58 | 2022-2025 | Xcopri |
| Biogen, INC. | $345.10 | 2023-2025 | Tysabri, Vumerity, Skyclarys |
| Novartis Pharmaceuticals Corporation | $323.52 | 2019-2025 | |
| Genentech USA, INC. | $322.94 | 2023-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Argenx US, INC. | $305.05 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Teva Pharmaceuticals USA, INC. | $294.57 | 2023-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Merz Pharmaceuticals, LLC | $272.34 | 2022-2025 | Xeomin |
| Merz North America, INC. | $241.67 | 2019 | |
| Lundbeck LLC | $238.13 | 2022-2025 | Vyepti, Rexulti |
| Sumitomo Pharma America, INC. | $210.97 | 2023-2024 | Aptiom |
| Celgene Corporation | $204.95 | 2022-2025 | Zeposia |
| Mdd US Operations, LLC | $185.90 | 2019-2025 | Gocovri, Apokyn, Xadago |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $177.78 | 2022-2025 | Nuplazid, Daybue |
| Eisai INC. | $165.57 | 2022-2025 | |
| Genzyme Corporation | $164.16 | 2024 | |
| Neurocrine Biosciences, INC. | $151.47 | 2022-2024 | Ingrezza, Ongentys |
| Harmony Biosciences LLC | $139.10 | 2023-2025 | Wakix |
| Ge Healthcare | $116.94 | 2022-2025 | |
| Kyowa Kirin, INC. | $96.97 | 2022-2024 | Nourianz |
| Lilly USA, LLC | $96.45 | 2024-2025 | Amyvid, Emgality, Kisunla |
| Alexion Pharmaceuticals, INC. | $93.96 | 2024-2025 | Ultomiris |
| Otsuka America Pharmaceutical, INC. | $71.80 | 2023-2025 | Rexulti |
| Boston Scientific Corporation | $68.16 | 2023-2025 | Wavewriter Alpha Prime 16, Vercise |
| Axsome Therapeutics, INC. | $56.78 | 2025 | Symbravo |
| Tg Therapeutics, INC. | $50.59 | 2025 | |
| Amgen INC. | $50.44 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $45.21 | 2025 | Crexont |
| Abbott Laboratories | $43.76 | 2022-2023 | Infinity |
| Hospira, INC. | $42.09 | 2024-2025 | |
| Grifols USA, LLC | $41.57 | 2019-2023 | Gamunex-C |
| Neurelis, INC. | $39.59 | 2023-2025 | Valtoco |
| Tonix Medicines, INC. | $34.66 | 2025 | Zembrace Symtouch |
| Averitas Pharma INC. | $34.28 | 2025 | Qutenza |
| Myriad Genetic Laboratories, INC. | $33.42 | 2021 | |
| Upsher-Smith Laboratories LLC | $32.81 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.37 | 2022 | |
| Allergan, INC. | $28.92 | 2020 | |
| Corium, LLC | $26.40 | 2023 | Adlarity |
| Blue Earth Diagnostics | $24.14 | 2024 | |
| Octapharma USA, INC. | $23.64 | 2025 | Panzyga |
| Janssen Biotech, INC. | $20.78 | 2025 | |
| Impel Pharmaceuticals INC. | $20.48 | 2023 | Trudhesa |
| Medtronic, INC. | $20.11 | 2022 | |
| Jazz Pharmaceuticals INC. | $19.79 | 2025 | |
| Biotronik Nro, INC. | $19.30 | 2023 | Biotronik |
| Nevro Corp. | $18.12 | 2024 | Senza |
| Ipsen Biopharmaceuticals, INC | $16.86 | 2023 | Dysport |
| Idorsia Pharmaceuticals US INC | $14.27 | 2023 | Quviviq |
| Emd Serono, INC. | $13.17 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.